(Q80194480)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449446%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Pharmacotherapy for schizophrenia and co-occurring substance use disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449446%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Alan I Green

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449446%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449446%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

published in

Neurotoxicity Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449446%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449446%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449446%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

33-40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17449446%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03033480

29 December 2019

exact match

0 references

cites work

Clozapine reverses cocaine craving in a treatment-resistant mentally ill chemical abuser: a case report and a hypothesis

1 reference

12 December 2020

Disulfiram in the treatment of alcoholic patients with schizophrenia

1 reference

12 December 2020

Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study

1 reference

12 December 2020

Aripiprazole in schizophrenia with cocaine dependence: a pilot study

1 reference

12 December 2020

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

1 reference

12 December 2020

Substance abuse and the onset of schizophrenia.

1 reference

12 December 2020

Schizophrenia: a neural diathesis-stress model

1 reference

12 December 2020

Outpatient treatment of patients with substance abuse and coexisting psychiatric disorders.

1 reference

12 December 2020

Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences

1 reference

12 December 2020

Decreased substance use in chronically psychotic patients treated with clozapine

1 reference

12 December 2020

Moderate drinking among people with severe mental illness

1 reference

12 December 2020

A neurobiological basis for substance abuse comorbidity in schizophrenia

1 reference

12 December 2020

Olanzapine treatment for patients with schizophrenia and substance abuse

1 reference

12 December 2020

Clozapine decreases smoking in patients with chronic schizophrenia

1 reference

12 December 2020

Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care

1 reference

12 December 2020

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

12 December 2020

Olanzapine treatment for patients with schizophrenia and cocaine abuse

1 reference

12 December 2020

Pharmacological treatment of substance-abusing schizophrenic patients

1 reference

12 December 2020

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

1 reference

12 December 2020

Substance misuse at presentation to an early psychosis program

1 reference

12 December 2020

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

1 reference

12 December 2020

Adjunctive desipramine in the treatment of cocaine abusing schizophrenics

1 reference

12 December 2020

Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Examining adherence to medication and substance use as possible confounds of duration of untreated psychosis

1 reference

12 December 2020

Alcohol dependence and hospitalization in schizophrenia

1 reference

12 December 2020

The association between high nicotine dependence and severe mental illness may be consistent across countries.

1 reference

12 December 2020

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

1 reference

12 December 2020

Psychotogenic drug use and neuroleptic response

1 reference

12 December 2020

Evolving use of buprenorphine in the treatment of addiction

1 reference

12 December 2020

The neural circuitry of reward and its relevance to psychiatric disorders

1 reference

12 December 2020

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence

1 reference

12 December 2020

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

1 reference

12 December 2020

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

1 reference

12 December 2020

Haloperidol increases smoking in patients with schizophrenia

1 reference

12 December 2020

Examining an affect regulation model of substance abuse in schizophrenia. The role of traits and coping.

1 reference

12 December 2020

Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature

1 reference

12 December 2020

Patterns of current and lifetime substance use in schizophrenia

1 reference

12 December 2020

Olanzapine for cocaine craving and relapse prevention in 2 patients.

1 reference

12 December 2020

Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

1 reference

12 December 2020

Disulfiram treatment for alcoholism in severe mental illness

1 reference

12 December 2020

Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation or discontinuation.

1 reference

12 December 2020

A Review of Treatments for People with Severe Mental Illnesses and Co-Occurring Substance Use Disorders.

1 reference

12 December 2020

Adjunctive imipramine in substance-abusing dysphoric schizophrenic patients

1 reference

12 December 2020

A placebo controlled trial of bupropion for smoking cessation in schizophrenia

1 reference

12 December 2020

Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes

1 reference

12 December 2020

Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy.

1 reference

12 December 2020

Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.

1 reference

12 December 2020

Treatment of schizophrenia and comorbid substance use disorder

1 reference

12 December 2020

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

1 reference

12 December 2020

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial

1 reference

12 December 2020

Clozapine and substance abuse in patients with schizophrenia

1 reference

12 December 2020

Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia

1 reference

12 December 2020

Substance use disorder comorbidity among inpatient youths with psychiatric disorder

1 reference

12 December 2020

Relapse in schizophrenia: is there a relationship to substance abuse?

1 reference

12 December 2020

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

1 reference

12 December 2020

Substance abuse in schizophrenia: a review

1 reference

12 December 2020

Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence

1 reference

12 December 2020

Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness

1 reference

12 December 2020

Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity

1 reference

12 December 2020

Medication noncompliance and substance abuse among patients with schizophrenia

1 reference

12 December 2020

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches

1 reference

12 December 2020

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

1 reference

12 December 2020

A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice

1 reference

12 December 2020

The cost of treating substance abuse patients with and without comorbid psychiatric disorders.

1 reference

12 December 2020

Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups

1 reference

12 December 2020

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

1 reference

12 December 2020

Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey

1 reference

12 December 2020

Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia

1 reference

12 December 2020

Six-month outcomes for patients who switched to olanzapine treatment

1 reference

12 December 2020

Prevalence of smoking in psychiatric patients

1 reference

12 December 2020

Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse.

1 reference

12 December 2020

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

12 December 2020

Assessing substance use disorder in persons with severe mental illness

1 reference

12 December 2020